A phase III comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus docetaxel in patients with previously treated advanced or metastatic squamous cell non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Borghaei, H.; Lynch, T. J.; Rizvi, N. A.; Chow, L. Q. M.; Reilly, R.; Crinò, L.; Buyse, M. E.; Ezzeddine, R.; Lestini, B. J.; Brahmer, J. R. |
| Abstract Title: | A phase III comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus docetaxel in patients with previously treated advanced or metastatic squamous cell non-small cell lung cancer (NSCLC) |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419605511 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.tps8122 |
| Notes: | Meeting Abstract: TPS8122 -- Source: Wos |
